Tecan and Enigma Diagnostics sign global manufacturing and supply agreement for point-of-care Molecular Diagnostics instruments

02-08-2010: The Tecan Group and Enigma Diagnostics Limited announced the signing of a manufacturing and supply agreement for Enigma's ML instruments. Under the agreement, Tecan will industrialize and deliver commercially manufactured ML instruments for Enigma's global market supplies for an initial five-year contract and will also manage the ML instrument's supply chain. Financial details of the agreement were not disclosed.

John McKinley, Chairman and CEO of Enigma, said: "This is a milestone agreement for Enigma. We chose Tecan for its leading reputation as a developer and manufacturer of commercial medical instruments and its global range of technical and support services network. This represents the first of a number of potential additional agreements relating to Tecan's support of the Enigma ML system."

Contact / Request information

Request further information free of charge:

Facts, background information, dossiers
More about Enigma Diagnostics
Most read news
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE